首页> 外国专利> WATER-BASED PHARMACEUTICAL PREPARATION OF 9-METHYL-3-(1 H-TETRAZOL-5-YL)-4H-PYRIDO (1,2-A)PYRIMIDIN-4-ONE

WATER-BASED PHARMACEUTICAL PREPARATION OF 9-METHYL-3-(1 H-TETRAZOL-5-YL)-4H-PYRIDO (1,2-A)PYRIMIDIN-4-ONE

机译:9-甲基-3-(1H-四唑-5-基)-4H-吡咯烷酮(1,2-A)嘧啶-4-酮的水基药物制备

摘要

PURPOSE: To obtain a water-based pharmaceutical preparation causing no crystal deposition even after preserved for a long period, highly excellent in preservability because of causing no TBX decomposition and being stable in pH level, thus esp. useful when used as a nasal drop, eye drop or liniment. ;CONSTITUTION: This water-based pharmaceutical preparation contains, as active ingredient, 9-methyl-3-(1H-tetrazol-5-yl)-4H-pyrido[1,2-a] pyrimidin-4-one or a physiologically permissible salt thereof {except those containing 0.05-0.5% (W/ V) of 9-methyl-3-(1H-tetrazol-5-yl)-4H-pyrido[1,2-a]pyrimidin-4-one potassium salt, 0.1-0.5% (W/V) of potassium hydrogenphosphate and 0.005-0.2% (W/V) of potassium dihydrogenphosphate}.;COPYRIGHT: (C)1996,JPO
机译:用途:获得即使在长时间保存后也不会结晶沉积的水基药物制剂,由于不会引起TBX分解并且在pH值方面稳定,因此具有极好的保存性。当用作滴鼻剂,滴眼剂或擦剂时很有用。 ;组成:这种水性药物制剂含有9-甲基-3-(1H-四唑-5-基)-4H-吡啶并[1,2-a]嘧啶-4-酮或生理允许的成分作为有效成分其盐{除了含有0.05-0.5%(W / V)的9-甲基-3-(1H-四唑-5-基)-4H-吡啶并[1,2-a]嘧啶-4-一钾盐的盐之外,磷酸氢二钾的0.1-0.5%(W / V)和磷酸二氢钾的0.005-0.2%(W ​​/ V)} .;版权:(C)1996,日本特许厅

著录项

  • 公开/公告号JPH0892093A

    专利类型

  • 公开/公告日1996-04-09

    原文格式PDF

  • 申请/专利权人 TOKYO TANABE CO LTD;

    申请/专利号JP19940276838

  • 发明设计人 YAZAKI TAKASHI;TAGUMA KAZUNORI;

    申请日1987-11-10

  • 分类号A61K31/505;A61K31/505;

  • 国家 JP

  • 入库时间 2022-08-22 03:55:34

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号